At 5.9% CAGR, Intravenous Immunoglobulin (IVIg) Market to reach 12800 Mn US$ by 2025- Baxter, Grifols, CSL, Octapharma, Biotest

This report focuses on the global Intravenous Immunoglobulin (IVIg) Market status, future forecast, growth opportunity, key market and key players. This information is extremely useful information for new and growing company to mark themselves over the market.

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

North America region is the largest supplier of intravenous immunoglobulin (IVIg), with a production market share nearly 48% in 2016. Europe is the second largest supplier of intravenous immunoglobulin (IVIg), enjoying production market share nearly 23% in 2016.

Get Exclusive Sample of Report on Intravenous Immunoglobulin (IVIg) market having 114 pages, profiling Top 14 Market Players is available at

North America is the largest sales place, with a sales market share nearly 44% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 22%.

Market competition is intense. Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The global Intravenous Immunoglobulin (IVIg) market is valued at 8120 million US$ in 2018 and will reach 12800 million US$ by the end of 2025, growing at a CAGR of 5.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intravenous Immunoglobulin (IVIg) market based on company, product type, end user and key regions.

The Intravenous Immunoglobulin (IVIg) market report covers major Manufactures Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang.

Report provides Intravenous Immunoglobulin (IVIg) Market Breakdown Data by its type like IVIg Liquid, IVIg Powder as well as by Applications such as Immunodeficiency, Autoimmune Disease, Acute Infection. Then it gives Intravenous Immunoglobulin (IVIg) Production Breakdown Data by Region United States, Europe, China, Japan, Other Regions.

The study objectives are:
To study and analyze the global Intravenous Immunoglobulin (IVIg) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intravenous Immunoglobulin (IVIg) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intravenous Immunoglobulin (IVIg) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Major Points from Table of Contents

1 Study Coverage

2 Executive Summary

3 Breakdown Data by Manufacturers

4 Breakdown Data by Product

5 Breakdown Data by End User

6 North America

7 Europe

8 Asia Pacific

9 Central & South America

10 Middle East and Africa

11 Company Profiles

12 Future Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

14 Value Chain and Sales Channels Analysis

15 Research Findings and Conclusion
and More

Inquire for Discount Upto 50% on Intravenous Immunoglobulin (IVIg) market 2019-25 Report at:

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808

Release ID: 493104